Gentiva Health Services (NASDAQ: GTIV) is in a space that's often overlooked by health care analysts; the company provides a variety of important health care services, such as nursing, to patients in both hospices and in their own homes.

Gentiva reported its third-quarter earnings today and posted a 6% drop in year-over-year revenue. Despite these seemingly poor results, its share price spiked an impressive 22%. What caused this surge? Can investors compare these report to upcoming earnings releases from competitors Amedisys (NASDAQ:AMED) and the LHC Group (NASDAQ:LHCG)?

In the following video, health care analysts Max Macaluso and David Williamson discuss this quarter's earnings and why Gentiva's share price soared.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.